Medicare Part D Payments for Generic Imatinib From 2017 to 2023.

ABSTRACT:

SUBMITTER: Dusetzina SB 

PROVIDER: S-EPMC10660232 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature